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AIMS OF THE STUDY 
1. To identify the patient population who would be most benefited with 
peritoneal dialysis in AKI . 
2. To analyse the factors affecting the outcome of patients with acute 
renal failure undergoing peritoneal dialysis . 
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                                    REVIEW OF LITERATURE 
           The management of  patients with acute renal failure (ARF) requires 
meticulous attention to fluid, acid-base, and electrolyte balance as well as 
the removal of uremic toxins. Peritoneal dialysis (PD) is an overlooked 
procedure for dialytic support in acute renal failure, as it is primarily used 
for the treatment of patients with end-stage renal disease (ESRD). 
Nevertheless, acute PD remains a viable option for the treatment of selected 
patients with AKI, particularly those who are hemodynamically 
compromised or have severe coagulation abnormalities or when other 
modalities are not readily available [1-3]. 
      The advantages, indications, and contraindications of acute PD and the 
components of an acute PD prescription will be reviewed here.  
ADVANTAGES OF PD  — Compared with other available modalities, PD 
has several advantages as a renal replacement therapy in patients with ARF: 
• It is widely available and technically easy to perform.  
• Large amounts of fluid can be removed in hemodynamically 
unstable patients; this fluid removal may also permit the 
administration of parenteral nutrition. 
• Disequilibrium syndrome is not precipitated because of slow 
solute removal.  
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• Easy and gradual correction of acid-base and electrolyte 
imbalance may be performed.  
• PD access placement is relatively easy, particularly in children.  
• Arterial or venous puncture and anticoagulation are not required.  
• It is a highly biocompatible technique.  
• Dosing is easy, particularly in children.  
Logistics — Acute PD is widely available and can be provided without 
significant inconvenience in any hospital. The procedure is relatively simple, 
can be performed by trained intensive care unit (ICU) nursing staff, and is 
less labor intensive compared to other continuous renal replacement 
therapies.  
Hemodynamic stability — The continuous nature of acute PD involves the 
slow removal of solutes (eg, urea) and fluid [4]. It is therefore desirable in 
hemodynamically unstable patients because large amounts of fluid can be 
removed over a prolonged period of time.  
Slow correction of metabolic imbalances — Acute PD enables continuous 
correction of acid-base status and electrolyte imbalance and the gradual 
removal of nitrogenous waste products. The slow removal of uremic toxins 
with acute PD is not associated with the development of the disequilibrium 
syndrome.  
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Easy access placement — Acute PD access can be achieved without serious 
difficulty by inserting a semirigid catheter or by placing a single cuff 
Tenckhoff catheter. The semirigid catheter insertion can be performed at the 
bedside by a nephrologist or surgeon. The Tenckhoff catheter is usually 
placed in the operating room by a surgeon; this flexible catheter is more 
comfortable for the patient who is moving around in bed and operative 
insertion avoids the occasional development of intestinal perforation with 
percutaneous insertion.  
Systemic anticoagulation not required — Since the PD procedure does not 
require systemic anticoagulation, excellent candidates for this modality 
include the following patients [4]: 
• Those with a bleeding diathesis  
• Patients in the immediate postoperative period  
• Trauma patients  
• Patients with intracerebral hemorrhage  
This is not an absolute advantage compared to hemodialysis since 
techniques are available to perform that latter procedure without systemic 
anticoagulant.  
Hyperalimentation — The use of hypertonic glucose PD solutions provides 
additional calories, which is of benefit in malnourished patients.  
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Tolerated in children — Acute PD has been frequently utilized and is the 
preferred form of therapy for dialysis among children with ARF [5,6]. The 
technique is convenient, relatively simple, and safe to perform in children, 
particularly since peritoneal access is easily obtained. Acute PD circumvents 
the need for arterial or venous puncture, both of which are difficult in 
children. 
INDICATIONS — The absolute indication for acute PD is the need for 
dialysis and the inability to perform any other renal replacement technique.  
Given the possible advantages of PD in the acute setting, other relative 
indications in adults include [4]: 
• Hemodynamically unstable patients  
• The presence of a bleeding diathesis or hemorrhagic conditions  
• Difficulty in obtaining blood access  
• Removal of high molecular weight toxins (>10 kD)  
• Clinically significant hypothermia and hyperthermia  
• Heart failure refractory to medical management  
CONTRAINDICATIONS — Since there are very few absolute 
contraindications for acute PD, most of the following conditions are only 
relative contraindications to this modality [4]: 
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• Recent abdominal and/or cardiothoracic surgery  
• Diaphragmatic peritoneal-pleural connections  
• Severe respiratory failure                                                            
• Life-threatening hyperkalemia  
• Extremely high catabolism  
• Severe volume overload in a patient not on a ventilator  
• Severe gastroesophageal reflux disease  
• Low peritoneal clearances  
• Fecal or fungal peritonitis  
• Abdominal wall cellulitis  
• Acute renal failure in pregnancy  
Recent abdominal and/or cardiothoracic surgery — The performance of 
acute PD may be difficult after abdominal surgery because of the violation 
of the peritoneal cavity and/or the placement of multiple abdominal drains. 
Abdominal drains increase the incidence of infection and confound fluid 
accounting with ongoing PD. The presence of abdominal hernia or 
intraabdominal adhesions in these patients may also make PD difficult. 
In addition, a diaphragmatic pleuroperitoneal communication may be present 
in patients after cardiothoracic (CT) surgery, thereby resulting in a large 
pleural effusion if PD is initiated.  However, CT surgery patients in whom 
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 the peritoneal cavity is intact and the integrity of the diaphragm is 
maintained, as well as those who have adequate vital capacity, are good 
candidates for acute PD. 
Respiratory insufficiency — Instilling fluid in the peritoneal cavity may 
increase intraabdominal pressure. Among patients with respiratory failure, 
this increase in pressure may compromise lung function (by limiting 
diaphragmatic excursion), thereby interfering with respiratory exchange.  
Severe gastroesophageal reflux disease — Increased intraabdominal pressure 
may worsen symptoms in patients with severe gastroesophageal reflux 
disease. If PD is required, such symptoms may be diminished with the 
placement of patients in body positions that minimize reflux. 
    
Severe hyperkalemia — Since PD does not remove potassium quickly, this 
modality is less desirable than other renal replacement therapies for the 
treatment of life-threatening hyperkalemia not responding to medical 
measures [7]. However, PD is still useful in the management of less severe 
hyperkalemia. In addition to the gradual removal of potassium, PD may also 
enhance the intracellular movement of potassium by generating bicarbonate 
and stimulating insulin production (via the administration of intraperitoneal 
glucose). 
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Severe volume overload — Since fluid removal is relatively limited with PD, 
patients with severe fluid overload may not be the best candidates for the 
modality. The rate of ultrafiltration in PD is dependent upon multiple factors, 
including the hypertonicity of the glucose solution; as a result, titration of 
fluid removal is not as easily achieved as it is with hemodialysis. 
Nevertheless, rapid volume removal is possible using high glucose 
concentrations and rapid exchanges. Patients with severe volume overload 
who are not supported by a ventilator probably should not be treated with 
PD. 
Hypercatabolic patient — Since acute PD is limited with respect to the rate 
of solute removal, severely hypercatabolic patients may  be offered an 
alternate renal replacement therapy [8]. 
ARF in pregnancy — Pregnant women with ARF are potentially good 
candidates for acute PD therapy because of the hemodynamic stability 
associated with the technique. However, there is a paucity of literature 
related to this issue. For obvious reasons, acute semirigid PD catheters 
should be avoided in this setting, and permanent PD catheters should be 
placed under direct visualization. 
TECHNIQUES — Acute PD can be performed intermittently or 
continuously (depending upon the desired amount of fluid and solute 
removal) and either manually or via an automated device [9]. 
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Acute manual PD is usually performed by nurses, since it requires constant 
supervision to ensure proper inflow and accurate dwell and drain times. 
Nursing assistance is also required for the maintenance of a record of 
exchange and drain volumes, and the documentation of net ultrafiltration. 
By comparison, the use of the automated device or cycler reduces the need 
for constant nursing supervision. The number of interruptions are 
significantly decreased, since large volumes of solutions can be prepared at 
the beginning of the procedure. 
Acute intermittent peritoneal dialysis — This technique can either be 
performed manually or can be delivered by an automated cycling device. 
The prescription usually involves short dwell times with 2.0 to 3.0 liter 
dialysate volumes. 
Chronic equilibrated peritoneal dialysis — Chronic equilibrated peritoneal 
dialysis (CEPD) is similar to chronic ambulatory peritoneal dialysis except 
that CEPD is performed in patients who are not ambulatory. This technique 
maintains a fairly stable fluid and solute balance and can be performed 
manually approximately four times daily with dwell times of four to six 
hours. CEPD can also be performed using an automated machine [10-12] 
that provides reliable and timed exchanges, thereby eliminating the need for 
interruptions or breaks in the sterile technique. CEPD dosing can be adjusted 
based upon the amount of fluid or nitrogenous wastes that have to be 
removed. 
 
     
10 
Tidal peritoneal dialysis — Tidal peritoneal dialysis (TPD) is a form of PD 
prescription that leaves a constant 'tidal' volume of 1.0 to 1.5 liters in the 
peritoneal cavity after the peritoneum is filled with a large (3.0 liter) 
dialysate volume. This allows for rapid exchange, using a cycler, of 
approximately half the peritoneal fluid instilled, thereby improving overall 
solute clearance [2,13]. 
Continuous flow peritoneal dialysis — Continuous flow peritoneal dialysis 
(CFPD) is an old technique that has regained popularity in the management 
of patients with ARF. CFPD utilizes two accesses, one for ingress and the 
other for egress of dialysate. A large intraperitoneal volume of dialysate is 
replenished in a continuous manner (single pass CFPD) or by using an 
external dialyzer to regenerate the sterile dialysate. This technique allows for 
increased dialysate flow rates of up to 300 mL/min and urea clearances in 
the range of 30 to 50 mL/min. Several catheter designs are now available for 
CFPD to facilitate adequate mixing of intraperitoneal dialysate [14,15] 
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ULTRAFILTERATION AND SOLUTE CLEARANCES OF DIFFERENT 
TECHNIQUES OF ACUTE PD  
 
 
 
 
 
 
 
 
Peritoneal access — One of the important determinants of a successful acute 
PD procedure is a reliable peritoneal access [9]. Peritoneal access can easily 
be obtained by inserting a semirigid acute catheter or a single cuff Tenckhoff 
catheter. Each has advantages and disadvantages. 
Semirigid acute catheter — The main advantage of a semirigid acute PD 
catheter is that it can be placed relatively easily at the bedside by a 
nephrologist, without the help of a surgeon [16]. Since it is usually 
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performed under local anesthesia, the potential risks of general anesthesia 
are avoided in the critically ill and unstable patient. 
However, there are several disadvantages to the use of semirigid catheters. 
The most important is the enhanced risk of infection because acute catheters 
do not have cuffs that protect against bacterial migration. The incidence of 
peritonitis is high, particularly if the catheter is left in place for more than 72 
hours [16,17]. There is also a risk of bowel perforation both at the time of 
insertion and with increased length of time of placement. Thus, these 
catheters must be removed within 72 hours. They are also uncomfortable for 
the alert patient. 
Cuffed permanent catheter — 
 Placement of a cuffed permanent catheter in ARF patients has several 
advantages [1,9,18,19]: 
• A good immediate functioning catheter is almost assured.  
• The overall incidence of infection is decreased.  
• The need for repeated punctures for intermittent dialysis is obviated; 
such punctures are occasionally required with the acute semirigid 
catheter since the course of ARF and the number of PD treatments is 
very unpredictable.  
• These soft catheters pose minimal risk to the bowel or other 
intraperitoneal organs and are more comfortable for the patient. 
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• These catheters are preferable in acute PD patients on cyclers, since 
acute semirigid catheters can sometimes trigger cycler alarms, 
leading to frequent interruptions of dialysis.  
 
These advantages must be carefully weighed against the potential risks, 
which include complications and morbidity associated with a surgical 
procedure (if not inserted at the bedside by a percutaneous technique), the 
risks of general anesthesia, and overall stability of the patients, particularly 
those in the intensive care unit.  
COMPONENTS OF ACUTE PERITONEAL DIALYSIS  
PRESCRIPTION — The standard acute PD prescription includes the 
following components: 
• Length of the dialysis session  
• Dialysate composition  
• Exchange volume  
• Inflow and outflow (drain) periods  
• Dwell time  
• Number of exchanges  
• Dialysate additives  
• Monitoring fluid balance  
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Length of dialysis session — The total length of an acute PD session 
averages about 24 to 72 hours since a session usually consists of 24 to 72 
exchanges, each of which lasts approximately one hour [17]. Nevertheless, 
the length of the PD session can vary significantly since it is dependent upon 
the cause and duration of ARF, the amount of solute and fluid removal that 
is desired, and the risk of infection, particularly with rigid catheters. 
     To accommodate the unpredictable course of ARF and the overall 
condition of these critically unstable patients, acute PD orders should only 
be written for a period of 24 hours. Periodic adjustments may need to be 
made based upon the patient evaluation and laboratory parameters, which 
should be performed at least daily. 
Dialysate composition — PD dialysate is available in standard hydrous 
dextrose concentrations of 1.5, 2.5, and 4.25 percent. Dialysate solutions 
should be warmed to body temperature prior to infusion to avoid discomfort 
and enhance solute transport. 
To obtain better ultrafiltration, it is reasonable to initiate acute PD in most 
patients with the 2.5 percent dialysate solution. An initial dialysis solution 
dextrose concentration of 1.5 percent may be more appropriate in patients 
with only moderate amounts of fluid overload and in those who are 
hemodynamically unstable. 
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          Dialysis solutions with higher dextrose concentration can be 
substituted based upon the amount of fluid removed and the patient's 
hemodynamic parameters. With a standard regimen, such as a two liter 
exchange volume and one hour dwell time, the following average amounts 
of fluid can be removed over a 24 hour period: 
• 2.5 liters with 1.5 percent dextrose  
• 4.5 liters with 2.5 percent dextrose  
• 8.5 liters with 4.25 percent dextrose  
The most practical way to achieve adequate fluid removal is by mixing and 
matching low and high dextrose concentration solutions. Once the patient is 
euvolemic, the dialysis solution should be switched to a dextrose 
concentration of 1.5 percent and the rate of exchange slowed. 
Exchange volume — The exchange volume is the amount of dialysate 
solution instilled into the peritoneal cavity during an exchange. Factors 
affecting this volume include the peritoneal cavity size, the presence of 
pulmonary disease and/or hernia(s), and the desire to limit leakage of 
dialysate. 
Peritoneal cavity size — The area of the peritoneal cavity, which can be 
estimated by the size of the patient, is the most important determinant of 
exchange volume. 
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    An average 50 to 60 kg adult can tolerate 1.5 liter exchanges without 
much difficulty. Smaller patients may require smaller exchange volumes, 
while exchange volumes of 2 to 2.5 liters may be utilized to improve dialysis 
efficiency in larger patients with no obvious contraindicated . 
Respiratory insufficiency — Patients with pulmonary diseases, such as 
pneumonia, chronic obstructive/restrictive lung disease and respiratory 
failure requiring ventillatory support, may require smaller exchange volumes 
to prevent compromise of diaphragmatic excursions and respiration. 
Hernias — In patients with abdominal wall or inguinal hernias, the exchange 
volume must be reduced to limit the increase in intra-abdominal pressure. 
Leakage — Most clinicians keep the exchange volume low for the first day 
to avoid leaks from the new catheter insertion site. The dialysate volume can 
then be gradually increased over the ensuing three to four days as tolerated 
by the patient. 
Inflow time — Inflow time is the time required to instill the dialysate into 
the peritoneal cavity, a process usually driven by gravity. Inflow usually 
takes approximately 10 to 15 minutes [9]. Factors that determine the inflow 
time include: 
• The dialysate volume  
• Degree of elevation of the dialysate bag above the patient's 
abdomen  
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• The presence of absence inflow resistance resulting from kinking 
of the peritoneal catheter or from reduced bowel motility  
To maximize the efficiency of dialysis, it is imperative to keep the inflow 
time to a minimum. 
Dwell time — The dwell time is the period in which the exchange volume 
remains in the peritoneal cavity, or the time between the end of inflow to the 
beginning of the drain period. 
The dwell time for standard acute PD is approximately 30 minutes, the time 
at which the gradients favoring urea and fluid removal are most favorable 
[9]. A dwell time of less than 30 minutes is usually not adequate [20]. 
Outflow time — Outflow time is the time required to drain the effluent 
dialysate from the peritoneal cavity. The outflow of the dialysate is 
controlled by gravity and usually takes about 20 to 30 minutes [9]. Some of 
the major determinants of the outflow time include: 
• Volume of the dialysate effluent to be drained  
• Outflow resistance, which results from kinks in the catheter, 
decreased bowel motility, and fibrin in the dialysate  
• The height difference between the patient and the drainage bag  
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As with the inflow time, it is important to keep the outflow time to a 
minimum. This can be done by adjusting the height of the drainage bag. 
It is extremely important to ensure complete drainage since incomplete 
drainage can result in progressive accumulation of dialysate in the peritoneal 
cavity, leading to respiratory embarrassment and/or abdominal discomfort. 
The PD orders should specify to "continue outflow until drainage stops" to 
avoid incomplete drainage. 
Number of exchanges — The number of exchanges is usually determined by 
the amount of fluid and solute removal required in a particular patient. 
Although it may vary, the usual number of exchanges is about 24 per day 
with standard acute PD and approximately four to six per day with CEPD. 
Dialysis solution additives — Drugs can be added to the dialysis solution to 
treat specific conditions. It is imperative to follow sterile technique when 
adding additives into dialysate solutions. Some of the commonly used 
dialysate additives are heparin , insulin, and potassium. 
Heparin — Heparin is usually added to dialysate solutions at a dose of 200 
to 500 units per liter to prevent fibrin clot formation, which can obstruct the 
peritoneal catheter [17]. Although it is usually added when plugs or strands 
of fibrin are visible in the drained fluid, heparin is more beneficial when 
added prophylactically. Once outflow obstruction is established, there is 
usually a poor response to heparin. Since heparin is not absorbed through the 
peritoneum, intraperitoneal heparin does not produce systemic 
anticoagulation. 
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Insulin — Insulin is commonly administered intraperitoneally in diabetic 
patients on PD. The use of hypertonic dextrose-containing dialysate 
solutions in diabetics results in a significant glucose load; this burden can 
result in uncontrolled blood glucose levels if not managed with appropriate 
insulin dosing. Intraperitoneal insulin is usually added to the dialysate 
solutions and adjusted based upon frequent blood glucose monitoring 
(approximately every six hours). One simple algorithm consists of an 
increasing insulin dose to be administered in the dialysis bag with increasing 
dextrose concentration [17]: 
• 4 to 5 units/L for 1.5 percent dextrose  
• 5 to 7 units/L for 2.5 percent dextrose  
• 7 to 10 units/L for 4.5 percent dextrose  
Potassium — Since standard PD solutions do not contain any potassium, 
potassium chloride should be added to the dialysate (usually 3 to 4 mmol/L) 
in hypokalemic patients. In patients with cardiac disease, particularly if 
treated with digoxin, the serum potassium should be closely monitored and 
the intraperitoneal potassium added to the dialysate to maintain the serum 
potassium at about 4 meq/L [17]. 
Monitoring fluid balance — It is essential to maintain accurate flow sheets, 
monitor intake and output records, and document net ultrafiltration in 
patients on acute PD. Daily intake and output charting and weights need to 
be incorporated into acute PD orders. 
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COMPLICATIONS — Acute PD is associated with complications, some of 
which are serious and potentially life-threatening [21,22]. Many are 
preventable. A brief listing of these complications is found in this section. 
        Peritonitis is most common complication associated with PD . It is 
diagnosed by presence of more than 100 cells/mm3 in dialysate with more 
than 50 % of them being neutrophils . Patients may complain of abdominal 
pain , fever , diarrhea or vomiting or the peritoneal fluid effluent may be 
cloudy  . Peritonitis complicates acute PD in up to 12% of cases, frequently 
developing within the first 48 hours .Because the major source of infection 
and of subsequent peritonitis is contamination during connection 
or disconnection of each new exchange, infection is more common with 
open-drainage systems(42) 
 
Mechanical complications — Most of the mechanical complications are not 
a serious threat to life, but may result in reduced dialysis efficiency. These 
include the following: 
Abdominal pain or discomfort — Mild abdominal pain or discomfort is 
common and is usually secondary to abdominal distention. By comparison, 
moderate to severe pain may be due to a catheter-related complication and 
warrants investigation. Marked pain on inflow of dialysis solution may be a 
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result of the solution’s low pH, its low temperature, the “jet flow” from a 
straight catheter tip, or distension of the tissue around the catheter.   
                 This pain may be relieved by alkalinization of the solution with 
sodium bicarbonate (5 – 25 mEq/L), by warming the solution, and by 
choosing a lower infusion rate. Localized outflow pain associated with 
drainage may indicate that the omentum or other tissues have trapped the 
catheter(42) 
Intraabdominal hemorrhage — Mild bleeding is frequent and can be 
observed with catheter placement. However, severe intraabdominal 
hemorrhage has been reported from catheters, particularly semirigid acute 
catheters. Bloody dialysate, which is frequently seen after catheter insertion, 
is usually a result of the lysis of peritoneal adhesions from a previous 
abdominal operation or of peritoneal irritation. The presence of a bleeding 
tendency predisposes to this complication. 
 
Leakage — Leakage around the PD catheter site is a common occurrence, 
which can be managed by reducing the exchange volume for the first 24 
hours. In some cases, temporary cessation of PD may be necessary. Early 
dialysate leakage may be seen in the presence of predisposing factors such 
as age over 60 years, obesity, diabetes mellitus, chronic use of steroids, 
multiparity, and a previous abdominal operation. 
                  Abdominal wall and genital edema have been attributed to 
peritoneal defects at the site of catheter insertion. Abdominal-wall edema 
should be suspected in cases of a sudden reduction in effluent volume and 
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 increased abdominal girth and body weight in the absence of edema 
elsewhere . 
Inadequate drainage : 
Inadequate drainage is usually due to decreased bowel motility. 
Administration of bowel cathartics will improve drainage in most situations, 
while manipulation of the catheter may occasionally be necessary.At times 
the omentum or peritoneum can occlude the outflow in the peritoneal 
catheter and contribute to inadequate drainage . 
Bowel perforation : 
Bowel perforations may be observed, particularly with the placement of 
semirigid acute PD catheters. Patients may have severe abdominal pain, 
blood-tinged peritoneal effluent, intraabdominal hemorrhage, and (rarely) 
shock. Therapy consists of the cessation of acute PD treatments, catheter 
removal, intravenous antibiotics, and bowel repair.  
Infectious complications : 
           Infectious complications are common, particularly peritonitis. The 
incidence of peritonitis can be significantly decreased by maintaining sterile 
precautions during the placement of acute PD catheters and by preventing 
contamination during exchanges.  In addition, a puncture site abscess can 
result from the bedside placement of acute PD catheters, particularly if 
meticulous attention is not given to sterile technique 
     
22 
Pulmonary complications  
Basal atelectasis and pneumonia : 
Atelectasis and pneumonia can result from the increase in intraabdominal 
pressure associated with acute PD treatments. 
Pleural effusion : 
Migration of fluid into the thoracic cavity, hydrothorax, can occur via a 
defect in the diaphragm or diaphragmatic lymphatics. A right sided effusion 
is most common. Decreasing intra-abdominal pressure by lowering 
exchange volumes and performing acute PD in a supine position may help in 
most situations. Pleurodesis is rarely required. 
Aspiration : 
 Increased intraabdominal aspiration may result in the aspiration of gastric 
contents, the incidence of which may be reduced with the use of a lower 
exchange volume. 
Cardiovascular complications  
Hypovolemia : 
 Excessive ultrafiltration [23] or diaphragmatic elevation secondary to 
increased intra-abdominal pressure (resulting in decreased venous return) 
can reduce effective tissue perfusion.  
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Cardiac arrhythmias : 
Cardiac arrhythmias are common, due most frequently to electrolyte and 
metabolic disturbances, or diaphragmatic elevation. 
Metabolic complications : 
 Metabolic complications are common and often preventable complications 
of acute PD: 
Hyperglycemia : Hyperglycemia can result from the high glucose 
concentration of the PD fluid. 
Hypoglycemia : Hypoglycemia may occur following the cessation of PD. 
Hypernatremia : 
 Hypernatremia can be induced by the disproportionate loss of free water in 
the PD fluid when hypertonic exchanges are repeatedly used. Since 
aquaporin 1 water channels in peritoneal capillaries are activated by the 
glucose-generated tonicity of the dialysate, free water moves down these 
channels. Sodium will then diffuse down its diffusion gradient from blood to 
dialysate through the small intercellular  pores. However, if the exchange is 
short in duration, there may be inadequate time for sodium diffusion to occur 
and the patient slowly becomes hypernatremic. This is best corrected by 
lengthening the duration of the exchanges so that diffusion can occur and/or 
using less hypertonic dialysate. 
     
24 
Hypokalemia : 
 As previously mentioned, hypokalemia may ensue because standard PD 
solutions do not contain any potassium. This can be corrected by adding 
potassium to the dialysate. 
Protein losses :  
Protein losses occur in the dialysate, occasionally exceeding 5 g/day. 
 
TRIALS FOR OUTCOME OF ACUTE KIDNEY INJURY WITH 
PERITONEAL DIALYSIS  
Value of Intermittent Peritoneal Dialysis in rural setup :                                        
245 patients who had undergone PD in Thanjavur Medical College Hospital 
because of ARF (108 snakebite cases, 45 acute diarrhoeal disease cases, 15 
obstetric renal failure patients, and 31 miscellaneous cases) They concluded 
that PD is a valuable procedure in ARF patients and that training the interns 
can allow them to manage ARF earlier in primary care centers and  this 
would save most of the patients and help to decrease the mortality due to 
ARF.   
          Edwin Fernando M , Venu G , Jayakumar M Low  Incidence  Of  
Acute  Peritonitis  In  Intermittent Peritoneal Dialysis  - An Experience From 
A Tertiary Care Unit Published in the Journal Of The Peritoneal Dialysis 
Society  Of India . 162 patients with AKI  and 901 patients with CKD  
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underwent PD in this study . 16 out of 162 patients developed infectious 
peritonitis and the incidence of peritonitis wes lower than that of those with 
CKD . Klebsiella (36%) , Staph. Aureus(31%) ,pseudomonas , E.Coli , and 
microccci were the commonest organisms (42). Aminoglycosides was found 
to be sensitive antibiotic for about 86% of patients .   
        Sridhar , Muthusethupathy , Shankar et.al had published an article in 
JAPI 1991 comparing the efficacy of acute intermittent peritoneal dialysis 
and intermittent hemodialysis in the management of patients with ARF due 
to acute diarrheal illness . This study concluded that peritoneal dialysis was a 
superior form of dialytic therapy compared to HD in patients with ADD as 
cause of AKI and that metabolic acidosis was the most important factor on 
multivariate analysis to be associated with a poor outcome in these 
patients .(43) 
        Part of the reason for the underuse of PD may be related to the 
perception that PD is not adequate for the treatment of ARF. How valid is 
this assumption? With respect to the concern that PD cannot control the 
uremia of acutely ill ARF patients because of the lower daily solute 
clearances with PD than with daily HD (16), most studies that have 
evaluated PD in hypercatabolic ARF reported that this mode of dialysis gave 
satisfactory control of fluid and metabolic derangements (26 - 31). However, 
major limitations of these studies were the lack of accurate measurements of 
dialysis adequacy and the lack of accurate measurements of catabolic status. 
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              Chitalia et al evaluated the adequacy of PD in ARF using accepted 
standards adequacy indices (Kt/V, normalized creatinine clearances) (42)and 
published his data in an article :”PD for hypercatabolic renal failure in 
developing countries”. 87 ARF patients with mild to moderate 
hypercatabolic ARF were included .He found that CPD fell just short of the 
adequacy standard.  TPD provides better clearances at the same dialysis 
volume at lower in-patient cost for those with ARF . Higher protein loss was 
the only limitation to TPD use in ARF.  
 
 
              To evaluate the adequacy of PD in ARF using accepted standards, 
Khanna’s team did a prospective, randomized crossover trial (32) in 87 ARF 
patients with mild-to-moderate hypercatabolic ARF. In this trial they 
analyzed the solute reduction indices (SRI) of both tidal PD and continuous 
equilibration peritoneal dialysis (CPD). Comparing adequacy indices (Kt/V,  
normalized creatinine clearances, SRI dialysate, SRI Kt/V), they showed 
that both tidal PD and CPD are reasonable options for mild-to-moderate 
hypercatabolic ARF, even though CPD fell just short of the adequacy 
standard. Tidal PD provides better clearances at the same dialysis volume at 
a lower inpatient cost for patients with ARF. Therefore, they concluded that, 
in developing centers that have access to cyclers to enable more rapid 
dialysis, the use of PD should be encouraged for the treatment of 
hypercatabolic ARF. 
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                However, a more recent trial, conducted in Vietnam, offered a 
different conclusion. Phu et al. (33) compared acute PD with pumped 
venovenous hemofiltration randomly performed in 70 adult patients with 
infection-associated ARF (falciparum malaria or sepsis). They concluded 
that hemofiltration was more effective in bringing about resolution of 
acidosis and lowering plasma creatinine levels — both of these effects were 
accompanied by a marked increase in survival. The group assigned to PD 
had a markedly increased risk of death (odds ratio 5.1, 95% confidence 
interval 1.6 – 16). However, these authors did not say how they compared 
the adequacy of solute removal between the two techniques.  In that study, 
42% of the PD patients had cloudy dialysate (an indication of possible 
infection). However, peritonitis was confirmed in only one patient — the 
only one treated for it.  It is of interest to note that the same group had earlier 
reported a dramatic reduction in mortality in malaria-associated renal failure 
 with the sole use of PD; the difference in case mix could perhaps account 
for this (34). It is therefore possible that, if careful attention is paid to the 
details of peritoneal access and to dialysis prescription (tidal versus 
equilibration), results equivalent to those obtained with HD may be achieved 
in ARF treated by PD.  
 
                 Continuous peritoneal dialysis was compared with daily 
hemodialysis in patients with acute kidney injury by Daniela Ponce Gabriel , 
Jacqueline Teixeira Caramori, Luis Cuadrado Martin, Pasqual Barretti and 
Andre Luis Balbi in The Department of Internal Medicine, University 
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 Hospital,  Brazil .  A total of 120 patients with acute tubular necrosis (ATN) 
were assigned to receive CPD or daily HD in a tertiary-care university 
hospital. The primary endpoint was hospital survival rate; renal function 
recovery and metabolic, acid–base, and fluid controls were secondary 
endpoints . Of the 120 patients, 60 were treated with CPD (G1) and 60 with 
daily HD . The two groups were similar in metabolic and acid–base control 
(after 4 sessions, BUN < 55 mg/dL: 46 ± 18.7 mg/dL vs 52 ± 18.2 mg/dL; 
pH: 7.41 vs 7.38; bicarbonate: 22.8 ± 8.9 mEq/L vs 22.2 ± 7.1 mEq/L in 
group 1 and 2 respectively ). Duration of therapy was longer in G2 (5.5 days 
vs 7.5 days; p = 0.02). Despite the delivery of different dialysis methods and 
doses, the survival rate did not differ between the groups (58% in G1 vs 52% 
in G2), and recovery of renal function was similar (28% vs 26%).  The 
authors concluded that high doses of CPD provided appropriate metabolic 
and pH control, with a rate of survival and recovery of renal function similar 
to that seen with dHD. Therefore, CPD can be considered an alternative to 
other forms of RRT in AKI 
         S.R. Ash had published an article titled “ Which Treatment for ARF in 
ICU?“  in Contributions to  Nephrology  2001. According to this author  
Peritoneal Dialysis for  acute renal failure of adults is a  safe, effective, and 
low-cost modality of treatment .This study was done in Greater Lafayette 
Health Systems (GLHS) and Arnett Clinic; Purdue University and 
HemoCleanse, Inc., West Lafayette, Ind., USA . He envisages the  perfect 
device for continuous arteriovenous hemofiltration and dialysis (CAVHD) 
for patients with  acute renal failure (ARF). This‘far-out’ ideal device would  
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provide:  (a ) permeability to uremic toxins and limited passage of albumin 
 and tightly bound toxins ( b) infallible blood access with blood flow rate of 
about 200 ml/min (c ) controllable ultrafiltration rate; (d ) biocompatibility 
 of blood pathways, (e )obviating need for anticoagulants; (f) impermeability 
to bacteria in dialysate, preventing septicemia after dialysate contamination; 
(g) permeability to white cells into dialysate if there is bacterial 
contamination, to limit proliferation and provide a visible sign of the 
contamination; (h) passage of effluent blood from the membranes directly to 
the liver, allowing metabolic conversion of lactate, glucose 
or various nutrients, and (i) ease of use, allowing continuous 24-hour 
dialysis by merely intermittently infusing and draining modest volumes of 
sterile dialysate through a permanent access. Most of these advantages are 
present in PD compared to CRRT / intermittent HD. 
              The author proposes that  internal CAVHD system already exists in 
all patients and can be used  without paying any royalty. It is the peritoneum. 
Like all dialysis procedures, peritoneal dialysis (PD) was first used in 
therapy of ARF . Now CAPD or cycler therapy supports about 15% of 
patients with ESRD in the USA . The success of CAPD in support of 
patients with ESRD has reminded physicians that PD can also be used for 
treatment of ARF in adults. In some countries such as Japan, PD was a more 
common choice for treatment of ARF in adults than CAVH in 1980’s . So 
the author says that  in ARF, PD should be  chosen for the same types of 
patients as those who require CRRT . Ash drew similar this conclusion after 
reviewing several studies, including his own (35). 
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            Although PD may be equivalent to HD in ARF, is it better than HD 
in any particular situation? The evidence for this is not solid. Several reports 
do suggest that a patient with ARF secondary to atheroembolic renal disease 
may have a better chance of recovery if PD is used over HD (36 , 37 ). Its 
advocates have advanced several reasons, including the absence of sudden 
 hemodynamic changes in PD as opposed to HD, and the avoidance of 
anticoagulation (which could therefore decrease the chances of further 
atheroembolism).Although attractive as a hypothesis, this assertion awaits 
formal testing in a clinical trial comparing these two modalities. 
 
          Furthermore, Katz et al.(38) report a beneficial role of PD in recovery 
of renal function when PD was the primary form of dialysis in patients with 
renal failure due to malignant hypertension. These workers all reported that 
blood pressure control, kidney size, and initial values of mean arterial 
pressure, serum creatinine, and urine output were predictors of outcome. 
 
       Peritoneal dialysis has also been found to be useful in patients with AKI 
due to acute pancreatitis in anecdotal reports . The proposed mechanism of 
benefit is the washout of inflammatory mediators from the peritoneal cavity 
due to pancreatic inflammation . But a randomized study (42) failed to show 
any difference in outcome in this group of patients among different modes of 
dialytic therapy which included PD . 
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 Peritoneal Dialysis International, Vol. 23, pp. 320–322 2003 
Dimitrios G. Oreopoulos3, Panduranga Rao1, Ploumis Passadakis2, 
        It might be apparent that factors beyond efficacy have dictated the 
decline in the use of PD for ARF. The importance of these factors should not 
be underestimated. They might be related to the perceived “labor intensive” 
aspect of PD, fear of a malfunctioning catheter (which in some instances 
may be real), insufficient exposure to PD during nephrology training, and, 
last, the comfort offered by the technology used for HD. Such psychological 
barriers are difficult to overcome, much more so than technical barriers 
(which can be and have been overcome). Only a concentrated effort by the 
PD community in educating the general nephrologist concerning the 
feasibility of PD in ARF, better clinical trials that harness the full potential 
of PD, and careful patient selection for the use of PD will bring PD back to 
the mainstream in the treatment of ARF. 
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MATERIALS AND METHODS : 
 
SETTING : 
 
The study – “ Peritoneal dialysis in patients with acute kidney injury “ was 
carried out in the Department of Nephrology , Madras medical college and  
Govt. General Hospital, Chennai . 
 
PERIOD OF STUDY : 
 
1st March 2007 to 30th  November 2008. 
 
DESIGN OF STUDY : 
 
Prospective study of consecutive patients with acute kidney injury who 
underwent peritoneal dialysis in Govt. General Hospital , Chennai . 
 
SAMPLE SIZE :  
 
151 patients who underwent peritoneal dialysis for acute kidney injury were 
included in this study . Indications for initiation of PD included volume 
overload, hyperkalemia refractory to medical treatment, metabolic acidosis , 
symptomatic uremia (pericarditis, encephalopathy, bleeding dyscrasia, 
nausea, vomiting ). 
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SELECTION OF PATIENTS :  
 
All patients with acute kidney injury who underwent peritoneal dialysis were 
included in this study . Patients with acute kidney injury underwent 
Peritoneal dialysis initially unless they had  
• Recent abdominal and/or cardiothoracic surgery  
• Severe respiratory failure  
• Life-threatening hyperkalemia  
• Extremely high catabolism  
• Severe volume overload in a patient not on a ventilator  
• peritonitis due to surgical causes  
• Abdominal wall cellulitis  
• Acute renal failure in pregnancy  
• Diaphragmatic peritoneal-pleural connections  
The following patients were taken up for peritoneal dialysis even if they had 
few of above conditions if they had  
 
• Refractory hypotension despite use of pressor agents  
 
• Requiring ventillatory support with AKI  
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Patients were transferred to Intermittent hemodialysis if they had  
           
• Persistent renal failure despite 2 peritoneal dialysis 
sessions  
 
• Persistent renal failure requiring dialysis more than 6 days 
after institution of peritoneal dialysis 
 
• Raising blood urea and creatinine levels following 
peritoneal dialysis compared to prior levels  
 
• Persistent hyperkalemia despite peritoneal dialysis 
 
• Persistent uremic symptoms despite peritoneal dialysis  
 
 
PROCEDURE OF INTERMITENT PERITONEAL DIALYSIS : 
 
IPD was done using Polyurethane IPD catheter( Dimensions: 280 x 5 x 
3.5mm, B Braun, Melsungen  AG, Germany) and IPD Y Transfer set( B 
Braun,  Melsungen AG, Germany).Constituents of IPD fluid ( 1L bottles, 
Parenteral Drugs India, Ltd) is given below . 
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   CONSTITUENTS & COMPOSITION OF IPD FLUID 
 
CONSTITUENT      CONCENTRATION 
Sodium           130mmol/L 
Calcium           1.5mmol/L 
Magnesium           0.75mmol/L 
Chloride           100 mmol/L 
Acetate           35 mmol/L 
 Dextrose Anhydrous           1.7 gm/100 ml 
 
 
     The PH of the fluid was adjusted with hydrochloric acid to 5.8 and the 
calculated osmolality  was 368. The following additives were used in the 
IPD bottles -  Inj. Heparin (unfractionated) 250 U/L,Inj.Pottasium Chloride 
2mEq/L and in select cases where fluid removal had to be quicker and more,  
Inj. 25% Dextrose 100cc /L was added to the peritoneal dialysis solution .  
IPD was carried out in a sterile room with strict aseptic precautions.  Each 
session consisted of 24 exchanges,  each exchange lasted an hour. The time 
taken for the inflow was 10-15 minutes,  Dwell time was 30 minutes and 
time taken for outflow was 15-20 minutes.  The volume of fluid during each 
exchange ranged from 1.5-2 L depending on the body weight(40ml//kg) 
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METHODS : 
 
     All patients with acute kidney injury undergoing peritoneal dialysis were 
evaluated by complete medical history , systemic examination ,standardized 
blood tests and imaging studies and were recorded in a standardized sheet . 
           Clinical history  and records regarding the cause of renal failure , 
diabetic or hypertensive status and drugs the patient had taken were 
obtained .  
           Clinical examination regarding the volume status , need for pressor 
agents , evidence of other organ failure – jaundice , encephalopathy , 
respiratory distress , need for ventillatory support were recorded . 
          Appropriate investigations for cause of renal failure , evidence of 
other organ dysfunction , and radiologic investigations as required were 
done .  
                    The primary outcomes were -  recovery from renal failure , 
patient transferred to hemodialysis or patient mortality . The last two 
outcomes were analysed as failure of peritoneal dialysis. Factors analysed 
for the outcomes were : age , sex , comobidities like – diabetis mellitus or 
hypertension or CCF , volume status at initiation of peritoneal 
dialysis ,presence of hypotension and its response to pressors or intravenous 
fluids , metabolic acidosis , hyperkalemia , serum creatinine at initiation of 
PD , urine output , hypercatabolism , coma , jaundice , raised liver enzymes , 
need for ventillatory support ,  presence of DIC or thrombocytopenia ,fluid 
removal  with PD , percentage fall in urea or serum creatinine values , 
peritonitis due to PD .  
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STATISTICAL ANALYSIS : 
 
Variables which were analyzed as qualitative data included sex , 
presence of co morbid illness like DM , HT , CCF , presence of 
hypovolemia , pedal edema , metabolic acidosis , hyperkalemia , oliguria , 
hypercatabolic renal failure , coma , jaundice , raised LFT enzyme levels , 
unresponsive hypotension , need for ventillatory support , DIC , 
thrombocytopenia . Qualitative data are given in frequencies with their 
percentages .  
                                Quantitative data were age, urine output per day , serum 
creatinine .Quantitative data are given in mean and standard deviation . 
Quantitative data were analyzed using student independent t test . 
Qualitative data were analyzed using  Fischer’s exact probability test and 
quantitative data were analyzed using independent – t – test . 
P value less than 0.05 were taken as significant. Multivariate analysis was 
done using logistic regression analysis . SPSS software was used for 
statistical analysis .  
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OBSERVATIONS : 
 
The total number of patients who underwent PD in our study was 151 . The 
distribution of patients according to their etiology of renal failure is depicted 
below .  
 
ADD 39
SEPSIS 36
MALARIA 14
LEPTO 18
FJUK 12 
SNAKE 7
DRUGS 11
CIRRHOSIS 8
OTHERS 9
 
 
ADD- Acute diarrheal illness 
FJUK- febrile illness with jaundice and kidney failure of unkown cause 
 
DISTRIBUTION  OF PATIENTS ACCORDING TO                                               
ETIOLOGY OF RENAL FAILURE  
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DISTRIBUTION OF PATIENTS ACCORDING TO THEIR OUTCOME 
 
The  distribution of patients according to their outcome : patients who 
recovered with peritoneal dialysis ; patients who required hemodialysis foe 
renal failure ; patients who expired is depicted below . 
0% 50% 100%
TOTAL
ADD
SEPSIS
MALARIA
LEPTO
FJUK
SNAKE
DRUGS
CIRRHOSIS
OTHERS
recover by PD
require HD
expire
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DISTRIBUTION OF PATIENTS ACCORDING TO THEIR OUTCOME  
 
 
744136151TOTAL 
.2501326OTHERS
.1764048CIRRHOSIS
.06356011DRUGS
.0061507SNAKE
.68072312FJUK
.733105318LEPTOSPIROSIS
.97574314MALARIA
.0011261836SEPSIS
.0142610 339ADD
P 
value
Recover 
with PD
Required 
HD
deathTotal 
 
        
P<0.05 significant  
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The following is the results of the factors that were analysed  in patients who 
underwent PD for AKI . 
 
FACTORS INFLUENCING OUTCOME OF PATIENTS WITH A.K.I  
UNDERGOING PERITONEAL DIALYSIS 
 
 
Total 151 death Transfer to 
HD 
Recover with 
PD 
 
P value 
NUMER IN EACH 
CATEGORY  
36 41 74  
AGE AVERAGE 51 39.6 34 .048 
MALES 25 28 55 .752 
DM 18 7 5 .029 
HT 15 8 11 .201 
CCF 8 0 4 .048 
HYPOVOLEMIA 5 16 45 .207 
PULM . EDEMA 10 2 0 .039 
MET ACIDOSIS 24 22 24 .624 
SERUM K > 6 15 1 2 .002 
CREATININE AVG 4.6 4.55 4.62 .657 
URINE < 500 36 31 53 .135 
AVERAGE  URINE 157 389 468 .046 
HYPERCATABOLIC 19 10 7 .087 
COMA 19 1 1 <.001 
JAUNDICE 22 12 28 .089 
BILURUBIN >5 20 6 10 .008 
OT/PT > 300 15 5 7 .046 
UNRESPONSIVE 
HYPOTENSION 
30 5 0 <.001 
VENTILLATOR 22 1 0 <.001 
DIC 14 5 1 .046 
LOW PLT 18 6 8 .026 
PERSIST  HIGH K 17 7 1 .035 
PERITONITIS 10 2 2 .402 
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FACTORS INFLUENCING OUTCOME OF PATIENTS WITH A.K.I DUE TO 
ACUTE DIARRHOEAL DISEASE UNDERGOING PERITONEAL DIALYSIS 
 
 
 
 
ADD - 39 death Transfer to 
HD 
Recover with 
PD 
 
P value 
NUMER IN EACH 
CATEGORY  
3 10 26  
AGE AVERAGE 65.3 32.9 34.5 .023 
MALES 2 7 19 .230 
DM 1 0 1 .143 
HT 1 1 3 .534 
HYPOVOLEMIA 1 4 20 .070 
MET ACIDOSIS 3 5 6 .777 
SERUM K > 6 3 1 0 <.0001 
CREATININE AVG 5.0 5.3 5.1 .356 
URINE < 500 3 8 26 .047 
AVERAGE  URINE 100 385 400 .021 
HYPERCATABOLIC 1 1 0 .097 
COMA 2 0 0 .007 
UNRESPONSIVE 
HYPOTENSION 
2 0 0 .007 
VENTILLATOR 2 0 0 .007 
PERSIST  HIGH K 1 1 1 .170 
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FACTORS INFLUENCING OUTCOME OF PATIENTS WITH A.K.I DUE TO 
SEPSIS  UNDERGOING PERITONEAL DIALYSIS 
 
 
SEPSIS - 36 death Transfer to 
HD 
Recover with 
PD 
 
P 
value 
NUMER IN EACH CATEGORY  18 6 12    
AGE AVERAGE                  52.4 44.3 35.8 .031 
MALES       11 4 8 .167 
DM 15 2 4 .043 
HT 8 2 5 .079 
CCF 7 0 4 .105 
HYPOVOLEMIA 2 3 6 .169 
PULM . EDEMA 7 1 0 .040 
MET ACIDOSIS 12 5 6 .238 
SERUM K > 6 2 0 0 .346 
CREATININE AVG 3.6 4.4 4 .341 
URINE < 500 16 4 7 .325 
AVERAGE  URINE 195 366 466 .037 
HYPERCATABOLIC 10 2 3 .267 
COMA 9 0 1 .011 
JAUNDICE 10 2 3 .226 
BILURUBIN >5 10 0 0 .001 
OT/PT > 300 9 0 0 .001 
UNRESPONSIVE 
HYPOTENSION 
9 5 0 .247 
VENTILLATOR 11 1 0 .001 
DIC 10 1 0 .001 
LOW PLT 11 0 0 .001 
PERSIST  HIGH K 8 2 0 .027 
PERITONITIS 5 0 1 .307 
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FACTORS INFLUENCING OUTCOME OF PATIENTS WITH A.K.I DUE TO 
MALARIA  UNDERGOING PERITONEAL DIALYSIS 
 
 
 
 
MALARIA-14 
 
death Transfer to 
HD 
Recover with 
PD 
 
P 
value 
NUMER IN EACH CATEGORY  3 4 7  
AGE AVERAGE 50 44.7 30.7 .035 
MALES 2 2 6 .445 
DM 2 1 0 .061 
HT 2 0 0 .013 
HYPOVOLEMIA 1 2 6 .223 
MET ACIDOSIS 3 3 5 .588 
CREATININE AVG 5.6 4.6 4.2 .659 
URINE < 500 3 1 5 .563 
AVERAGE  URINE 66.6 575 486 .003 
HYPERCATABOLIC 2 1 1 .452 
COMA 2 0 0 .015 
JAUNDICE 2 4 6 .438 
BILURUBIN >5 2 2 2 .358 
OT/PT > 300 2 1 2 .187 
UNRESPONSIVE 
HYPOTENSION 
2 0 0 .015 
VENTILLATOR 2 0 0 .015 
LOW PLT 2 1 5 .304 
PERSIST  HIGH K 2 2 0 .050 
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FACTORS INFLUENCING OUTCOME OF PATIENTS WITH A.K.I DUE TO 
LEPTOSPIROSIS UNDERGOING PERITONEAL DIALYSIS 
 
 
LEPTO 18 death Transfer to 
HD 
Recover with 
PD 
 
 
NUMER IN EACH 
CATEGORY  
3 5 10  
AGE AVERAGE 49..3 31.8 31.2 .041 
MALES 2 4 8 .305 
DM 1 0 0 .087 
HT 2 0 1 .124 
HYPOVOLEMIA 0 2 7 .424 
PULM . EDEMA 1 0 0 .232 
MET ACIDOSIS 3 4 7 .380 
CREATININE AVG 5.0 4.4 5.3 .235 
URINE < 500 3 5 8 .081 
AVERAGE  URINE 100 370 440 .032 
HYPERCATABOLIC 2 1 1 .432 
COMA 1 1 0 .281 
JAUNDICE 2 4 8 .305 
BILURUBIN >5 2 2 3 .357 
OT/PT > 300 2 1 2 .791 
UNRESPONSIVE 
HYPOTENSION 
2 0 0 .003 
DIC 1 2 0 .038 
LOW PLT 2 3 3 .244 
PERSIST  HIGH K 2 0 0 .023 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
 
CHARETERSTICS OF PATIENTS WITH SNAKE BITE AND AKI WHO 
UNDERWENT PERITONEAL DIALYSIS  
 
Statistical analysis could not be done due to the small number (7) of patients in 
this group . 
 
 
 
SNAKE-7 
 
death transferHD recoverPD 
 
NUMER IN EACH CATEGORY  0 5 1 
AGE AVERAGE 0 36 45 
MALES 0 5 1 
CCF 0 0 0 
HYPOVOLEMIA 0 3 1 
PULM . EDEMA 0 0 0 
MET ACIDOSIS 0 5 1 
SERUM K > 6 0 0 0 
CREATININE AVG 0 3.7 3.5 
URINE < 500 0 3 0 
AVERAGE  URINE 0 370 1100 
HYPERCATABOLIC 0 4 1 
COMA 0 0 0 
JAUNDICE 0 0 0 
BILURUBIN >5 0 0 0 
OT/PT > 300 0 1 0 
UNRESPONSIVE HYPOTENSION 0 0 0 
VENTILLATOR 0 0 0 
DIC 0 2 1 
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The age of patients was found to be an important determinant influencing 
outcome in patients with AKI undergoing PD . A pictoral representation of 
age of patients with the respective etiology of renal failure is depicted below . 
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The average urine output of  patients was also found to be an important 
determinant influencing outcome in  these patients  . A pictoral 
representation of average urine output of patients with the respective 
etiology of renal failure is depicted below. 
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DISCUSSION : 
 
      Peritoneal dialysis is an underutilized modality  as a form of renal 
replacement therapy in  the management of AKI  and has certain advantages 
over intermittent HD – easy to perform , widely available , 
hemodynamically more stable than intermittent HD , absence of dialysis 
dyseqlibrium syndrome ,gradual correction of electrolyte abnormalities , 
obviates need for heparin and vascular puncture .  
But the clearance of solutes is lesser than that obtained with intermittent HD . 
This nessecitates identifying the group of patients who will be most 
benefited from PD for AKI 
 
         This study reveals that peritoneal dialysis can be an effective modality 
of renal replacement therapy in acute renal failure in a subgroup of patients . 
Peritoneal dialysis has been found to be most useful in patients with AKI 
due to acute diarrhoeal disease .  
           
            Peritoneal dialysis was associated with a poorer outcome in patients  
with AKI due to sepsis . This should be due to the naturally poor outcome of 
patients with severe sepsis . Most of the patients with snake bite as a cause 
of renal failure eventually required hemodialysis for control of uremia / 
hyperkalemia and hence in this group of patients intermittent hemodialysis 
shoild be initiated early. 
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50%CIRRHOSIS
45.5%DRUGS
14.2%SNAKE
58.3%FJUK
55.5%LEPTOSPIROSIS
50%MALARIA
33.3%SEPSIS
66.6%ADD
PERCENTAGE OF PATIENTS WHO 
RECOVERED WITH PD 
 
         Among patients with acute kidney injury who underwent peritoneal 
dialysis the following factors were found to be associated with poor outcome 
or a  need to institute  hemodialysis for renal replacement therapy . 
 
1. elderly age . The average age of patients who expired while on 
PD was 51 yrs while the average age of patients who recovered 
with PD was 34 yrs . 
2. presence of comorbid illness – especially diabetis mellitus . 
This may reflect the severity of illness among these patients and 
their increased propensity for developing hospital acquired 
infections . 
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3. presence of pulmonary edema and hyperkalemia(serum K >6 
meq/L ) . PD was initiated for these patients  primary because 
of their other comorbid illness like hypotension and respiratory 
failure . The poor outcome with PD in this group of patients 
suggests that CRRT may be a better mode of renal replacement 
therapy in patients with hypotension and pulmonary edema. 
4. low urine output . patients who recoverd with PD had an 
average urine output of 468 ml/day whereas those who had 
expired had a urine output of 157 ml/day .  
5.  hypotension unresponsive to pressor therapy and IV fluid 
replacement 
6. evidence of other organ failure in association with renal failure 
as evidenced by – serum bilirubin >5 mg/dl , coma , respiratory 
failure requiring ventillatory support . 
7. evidence of DIC  
 
The factors that were not associated with a bad outcome with PD for patients 
with AKI were :  
  
1. gender of patient 
2. hypovolemia at initiation of PD . Patients with hypovolemia had 
a  trend towards a better outcome with peritoneal dialysis – 
which could be because hypovolemia being a  reversible factor 
significantly contributing to AKI . But the correlation was not 
statistically significant .  
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3. Metabolic acidosis at initiation of PD . A large group of our 
patients who underwent PD had acute diarrhoeal disease most of 
whom had metabolic acidosis – which was easily corrected by 
bicarbonate therapy  .Acute diarrhoeal disease patients with AKI 
had a better prognosis than other group of patients .  
4. Hypercatabolic renal failure . 52% patients who expired had 
hypercatabolism , 24 % patients who required HD and 10% 
patients who recovered with PD were hypercatabolic .But the p 
value was marginally insignificant ( p = .08 ) 
5. presence of jaundice or SGOT/SGPT > 100 was not significantly 
different between these groups , but severe jaundice with total 
bilirubin > 5 mg/dl was associated with bad outcome . 
6. Peritonitis associated with PD. 10 of our patients developed 
peritonitis , but peritonitis was not significantly contributing to  
a poorer outcome  . 
 
Among patients with acute diarrhoeal illness causing AKI the following 
factors were associated with poor response to PD as mode of RRT : 
1. elderly patients  
2. serum K > 6 meq/L 
3. coma  
4. unresponsive hypotension  
5. need for ventillatory support . 
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Among patients with sepsis causing AKI the following factors were 
associated with poor response to PD as mode of RRT  : 
1. elderly patients  
2. presence of pulmonary edema 
3. low urine output  
4. serum bilirubin > 5 mg/dl  
5. SGOT/SGPT > 300 IU/Dl 
6. need for ventillatory support 
7. evidence of DIC 
 
Among patients with malaria /leptospirosis causing AKI the following 
factors were associated with poor response to PD as mode of RRT :  
     1.elderly patients  
  2.low urine output 
  3.coma  
  4.unresponsive hypotension 
  5.need for ventillatory support 
  6.evidence of DIC 
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CONCLUSION : 
 
1. Peritoneal dialysis had been found to be an effective way of renal 
replacement therapy in patients with AKI due to diarrhoeal illness . 
2.  Patients with snake bite or sepsis as cause of AKI eventually required 
hemodialysis  or expired due to their illness and hence intermittent 
HD or CRRT should be considered in these patients . 
3. PD can be an effective way of RRT in patients with AKI who are 
                          relatively younger ,  
                         do not have comorbid illness like DM ,  
                         absence of pulmonary edema or hyperkalemia , 
                         absence of other organ dysfunction 
                         ( bilirubin > 5 mg /dl ,coma or respiratory failure ) and in 
                         absence of DIC . 
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